ArticleOrthopedic reviews2026
The Association Between Charcot-Marie-Tooth Disease and Developmental Dysplasia of the Hip: A Narrative Review.
Article in Orthopedic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Charcot-Marie-Tooth (CMT) disease, a condition comprising a variety of inherited peripheral neuropathies, is marked by progressive degeneration of motor and sensory nerves. The current review examines the link between CMT and developmental dysplasia of the hip (DDH), characterized by abnormal hip joint development. Although the frequency of DDH among CMT patients has been under-investigated, the musculoskeletal complications of CMT (including weakness and abnormal gait) may predispose individuals to hip dysplasia. This narrative review compiles data from 11 publications selected from a systematic search of PubMed and Web of Science. The criteria included established diagnosis of CMT and DDH in patients aged less than 14 years, English language, and availability of full text. This review examined patient characteristics, genetics, diagnosis, and treatment. Research demonstrates a high incidence of hip dysplasia among CMT patients, with some studies reporting 22% in clinical series. Patterns of diagnosis differ among subtypes, with earlier onset of Type-1 CMT. This link is influenced by genetic factors, such as duplication of the PMP22 gene, and family studies show vertical transmission. Diagnosis includes physical examination, X-rays and genetic analysis. Early intervention, including non-surgical and surgical treatment in severe cases, is crucial to management. The link between CMT and DDH highlights the importance of awareness and screening in at-risk groups. Appropriate screening and management algorithms can enhance quality of life. Additional epidemiological and genetic studies are needed to improve diagnostic and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.